**Exhibit      32.1**

**CERTIFICATION      OF **

**CHIEF      EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER **

**PURSUANT      TO 18 U.S.C. SECTION 1350**

| 1. | Such                Quarterly Report on Form 10-Q for the period ending September                30, 2008, fully complies with the requirements of section 13(a) or                15(d)                of the Securities Exchange Act of 1934;                and |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2. | The                information contained in such Quarterly Report on Form 10-Q for                the period ending September 30, 2008, fairly presents, in all                material respects, the financial condition and results of operations                of                Benda Pharmaceutical, Inc. |
|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Date:                November 18, 2008                              |
|---------------------------------------------------------------------|
|                                                                |
| */s/                Yiqing Wan*                                     |
| Yiqing                WanPresident,                CEO and Director |

----

**Exhibit      32.1**

**CERTIFICATION      OF **

**CHIEF      EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER **

**PURSUANT      TO 18 U.S.C. SECTION 1350**

| 1. | Such                Quarterly Report on Form 10-Q for the period ending September                30, 2008, fully complies with the requirements of section 13(a) or                15(d)                of the Securities Exchange Act of 1934;                and |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 2. | The                information contained in such Quarterly Report on Form 10-Q for                the period ending September 30, 2008, fairly presents, in all                material respects, the financial condition and results of operations                of                Benda Pharmaceutical, Inc. |
|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Date:                November 18, 2008                                                                |
|-------------------------------------------------------------------------------------------------------|
|                                                                                                  |
| */s/                Eric Yu*                                                                          |
| Eric                YuCFO                and Principal Accounting                Officer and Director |

----